Page last updated: 2024-08-21

dihydroberberine and Idiopathic Parkinson Disease

dihydroberberine has been researched along with Idiopathic Parkinson Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cao, X; Cong, L; Fu, J; Gao, TL; Han, P; Jiang, JD; Li, XY; Lin, Y; Ma, SR; Pan, LB; Peng, R; Shou, JW; Tong, Q; Wang, Y; Wen, BY; Yu, H; Yu, JB; Zhang, XF; Zhang, ZW; Zhao, ZX	1

Other Studies

1 other study(ies) available for dihydroberberine and Idiopathic Parkinson Disease

Article	Year
Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson's disease by regulating gut microbiota. Signal transduction and targeted therapy, 2021, 02-24, Volume: 6, Issue:1 Topics: Animals; Berberine; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Enterococcus faecalis; Enterococcus faecium; Gastrointestinal Microbiome; Humans; Levodopa; Mice; Parkinson Disease; Tyrosine 3-Monooxygenase	2021

Article

Year

Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson's disease by regulating gut microbiota.

Signal transduction and targeted therapy, 2021, 02-24, Volume: 6, Issue:1

Topics: Animals; Berberine; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Enterococcus faecalis; Enterococcus faecium; Gastrointestinal Microbiome; Humans; Levodopa; Mice; Parkinson Disease; Tyrosine 3-Monooxygenase

2021